IP Library Granted Patent US 11,071,455
Granted Patent B2
US 11,071,455 · App. 15/810,822 · Granted Jul 27, 2021

Continuous analyte monitoring system

Inventors: Andrew DeHennis (Germantown, MD); Barkha Raisoni (Germantown, MD); Todd Whitehurst (Germantown, MD)
Assignee: Senseonics, Incorporated
A61B5/0022A61B5/002A61B5/1459A61B5/14532A61B5/74A61B5/7455G06F19/00G16H40/63A61B5/7275A61B2560/0209A61B2560/0219
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,071,455
App. No.
15/810,822
Granted
Jul 27, 2021
Kind
B2
Abstract

An improved analyte monitoring system having a sensor and a transceiver with improved communication and/or user interface capabilities. The transceiver may communicate with and power the sensor. The transceiver may receive one or more analyte measurements from the sensor and may calculate one or more analyte concentrations based on the received analyte measurements. The transceiver may generate analyte concentration trends, alerts, and/or alarms based on the calculated analyte concentrations. The system may also include a display device, which may be, for example, a smartphone and may be used to display analyte measurements received from the transceiver. The display device may execute a mobile medical application. The system may include a data management system, which may be web-based.

Claims (62)

1. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:

(A) an analyte sensor;

(B) an on-body transceiver comprising:

(B1) a sensor interface configured to receive data signals from the analyte sensor;

(B2) a display interface that comprises a wireless communication circuit; and

(B3) a processor configured to:

calculate an analyte concentration based on the received data signals,

generate a signal to initiate a vibratory alert based on the calculated analyte concentration, and

cause the display interface to wirelessly convey analyte information including the calculated analyte concentration and the generated signal to initiate the vibratory alert;

(C) a display device configured to receive the analyte information, vibrate in response to the generated signal to initiate the vibratory alert, and execute a mobile medical application that displays the calculated analyte concentrations; and

(D) adhesive configured to hold the transceiver in place on the body of the living organism.

2. The system of claim 1 , wherein the analyte information conveyed to the display device comprises the received data signals, and the mobile medical application is configured to calculate analyte concentration.

3. The system of claim 1 , wherein the analyte sensor is an implantable sensor.

4. The system of claim 1 , wherein the display device is a smartphone.

5. The system of claim 1 , wherein the wireless communication circuit employs a wireless communication standard to wirelessly convey the calculated analyte concentrations.

6. The system of claim 5 , wherein the wireless communication standard is a Bluetooth standard.

7. The system of claim 1 , wherein the transceiver does not display the calculated analyte concentrations.

8. The system of claim 1 , wherein the display device is configured to upload analyte concentrations to a web-based data management system.

9. The system of claim 8 , further comprising the web-based data management system.

10. The system of claim 1 , wherein the processor of the transceiver is configured to perform an analyte concentration calibration based on one or more user-entered calibration points.

11. The system of claim 10 , wherein the display interface of the transceiver receives the one or more user-entered calibration points from the display device.

12. The system of claim 11 , wherein the display device is configured to facilitate user entry of the calibration points.

13. The system of claim 1 , wherein the processor of the transceiver is further configured to calculate an analyte concentration trend based on the calculated analyte concentration.

14. The system of claim 1 , wherein the analyte sensor comprises:

(A1) an analyte indicator configured to produce a detectable property based on the amount or concentration of the analyte in proximity to the analyte indicator;

(A2) sensor elements configured to generate a data signal based on the detectable property produced by the analyte indicator; and

(A3) a transceiver interface configured convey data signals generated by the sensor elements.

15. The system of claim 14 , wherein the analyte sensor further comprises a sensor housing, and the sensor elements and transceiver interface are contained within the sensor housing.

16. The system of claim 14 , wherein the detectable property is an optical property.

17. The system of claim 14 , wherein the sensor elements comprise a light source and a photodetector.

18. The system of claim 14 , wherein the transceiver interface of the analyte sensor is an antenna configured to wirelessly convey the data signals generated by the sensor elements, and the sensor interface of the transceiver is an antenna configured to wirelessly receive the data signals from the antenna of the analyte sensor.

19. The system of claim 18 , wherein the antennas of the analyte sensor and transceiver are inductive elements.

20. The system of claim 14 , wherein the sensor interface of the transceiver and the transceiver interface of the analyte sensor are a wire connected through a transdermal needle tip.

21. The system of claim 1 , wherein the analyte is glucose.

22. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:

(A) an analyte sensor;

(B) an on-body transceiver comprising:

(B1) a sensor interface configured to receive data signals from the analyte sensor;

(B2) a processor configured to:

calculate an analyte concentration based on the received data signals,

calculate an analyte concentration trend based on the calculated analyte concentration, and

generate a signal to initiate a vibratory alert based on the calculated analyte concentration and the calculated analyte concentration trend; and

(B3) a display interface configured to convey analyte information;

(C) a display device configured to receive the analyte information and execute a mobile medical application that displays analyte concentrations;

(D) adhesive configured to hold the transceiver in place on the body of the living organism; and

(E) a vibration motor configured to vibrate in response to the generated signal to initiate the vibratory alert.

23. The system of claim 22 , wherein the analyte information conveyed to the display device comprises the calculated analyte concentration.

24. The system of claim 22 , wherein the display interface of the transceiver comprises a wireless communication circuit configured to wirelessly convey the analyte information.

25. The system of claim 24 , wherein the conveyed analyte information includes the calculated analyte concentration and the generated signal to initiate the vibratory alert.

26. The system of claim 22 , wherein the conveyed analyte information includes the generated signal to initiate the vibratory alert, and the display device comprises the vibration motor that is configured to vibrate in response to the generated signal to initiate the vibratory alert.

27. The system of claim 22 , wherein the on-body transceiver comprises the vibration motor that is configured to vibrate in response to the generated signal to initiate the vibratory alert.

28. A system for detecting an amount or concentration of an analyte in vivo within a living organism, the system comprising:

(A) an analyte sensor;

(B) an on-body transceiver comprising:

(B1) a sensor interface configured to receive data signals from the analyte sensor;

(B2) a processor configured to:

calculate an analyte concentration based on the received data signals, and

generate a signal to initiate a vibratory alert based on the calculated analyte concentration;

(B3) a display interface configured to convey analyte information; and

(B4) a notification device including a vibration motor, and the transceiver is configured to use the generated signal to initiate the vibratory alert to control the notification device to generate a vibrational signal;

(C) a display device configured to receive the analyte information and execute a mobile medical application that displays analyte concentrations; and

(D) adhesive configured to hold the transceiver in place on the body of the living organism.

Assignments (12)
SECURITY INTEREST Recorded Sep 11, 2023
From: SENSEONICS, INCORPORATED
To: HERCULES CAPITAL, INC.
Reel/Frame 064866/0963 →
RELEASE OF SECURITY INTEREST Recorded Sep 7, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 064834/0962 →
RELEASE OF SECURITY INTEREST Recorded Apr 14, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: SENSEONICS HOLDINGS, INC.; SENSEONICS, INCORPORATED
Reel/Frame 063338/0890 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 2, 2021
From: DEHENNIS, ANDREW; RAISONI, BARKHA; WHITEHURST, TODD
To: SENSEONICS, INCORPORATED
Reel/Frame 055810/0955 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 14, 2020
From: SENSEONICS, INCORPORATED
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 053496/0292 →
RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Aug 14, 2020
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, COLLATERAL AGENT
To: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
Reel/Frame 053498/0275 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT - FIRST LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052492/0109 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT -SECOND LIEN Recorded Apr 24, 2020
From: SENSEONICS, INCORPORATED; SENSEONICS HOLDINGS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
Reel/Frame 052490/0160 →
RELEASE OF SECURITY INTEREST Recorded Mar 23, 2020
From: SOLAR CAPITAL LTD., AS AGENT
To: SENSEONICS, INCORPORATED
Reel/Frame 052207/0242 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Aug 1, 2019
From: SENSEONICS, INCORPORATED
To: SOLAR CAPITAL LTD., AS AGENT
Reel/Frame 049926/0827 →
RELEASE OF SECURITY INTEREST Recorded Jul 25, 2019
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
To: SENSEONICS, INCORPORATED
Reel/Frame 049873/0713 →
SECURITY INTEREST Recorded Jan 26, 2018
From: SENSEONICS, INCORPORATED
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT AND AS LENDER
Reel/Frame 045164/0154 →
Cited By (1)
US 12,507,921